Dr. Kevin Bainey, Director of the CVC ECG Core Laboratory, was featured on multiple news outlets discussing key results from the recent publication Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction in Clinical Practice: Insights From the Vital Heart Response Registry. This publication was also coauthored by several other members of the CVC faculty and biostatistics team.
The research findings for this study suggest that treating a serious type of heart attack with clot-busting drugs alongside the prevailing standard treatment may lead to patients achieving better heath outcomes.
You can read more about the study findings on Folio, the Edmonton Journal, and CBC.
